Axio BioPharma: Our Story
Axio BioPharma is a Contract Development and Manufacturing Organization (CDMO) focused on mammalian expressed proteins. Using our proprietary AI model, we predict robust and scalable manufacturing processes from just an amino acid sequence, accelerating drug development from concept to clinic.
What We Do
Axio BioPharma combines traditional biopharmaceutical development and manufacturing services with the power of AI to increase development speed, manufacturing scalability, and improve overall efficiency. Our AI-driven approach minimizes traditional iterative experimentation, leading to significant time and cost savings.